<?xml version="1.0" encoding="UTF-8"?>
<ref id="JVEv5-bib-0066">
 <label>66.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Harper</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Adams</surname>
    <given-names>KJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bossi</surname>
    <given-names>G</given-names>
   </name>
   <etal>et al.</etal>
  </person-group>
  <article-title>An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules</article-title>. 
  <source>PLoS One</source>
  <year>2018</year>; 
  <volume>13</volume>
  <bold>(</bold>
  <issue>10</issue>
  <bold>)</bold>: 
  <comment>e0205491</comment>.
 </mixed-citation>
</ref>
